Letter in response to: Coagulation markers are independent predictors of increased oxygen requirements and thrombosis in COVID-19

J Thromb Haemost. 2020 Dec;18(12):3382-3384. doi: 10.1111/jth.15080.

Authors

Pervinder Bhogal¹, Melanie Jensen², George Collins², Oliver Spooner³, Levansri Makalanda¹, Dan Hart⁴, Ounali Jaffer¹

Affiliations

¹ Department of Interventional Neuroradiology, The Royal London Hospital, Barts NHS Trust, London, UK.
² Department of Cardiology, St. Bartholomew's Hospital, Barts NHS Trust, London, UK.
³ Department of Stroke Medicine, The Royal London Hospital, Barts NHS Trust, London, UK.
⁴ Department of Haematology, The Royal London Hospital, Barts NHS Trust, London, UK.

No abstract available

Keywords: COVID 19; anfibatide; caplacizumab; endotheliopathy; microthrombosis.

Publication types

Letter
Comment

MeSH terms

Biomarkers
COVID-19*
Humans
Oxygen
SARS-CoV-2
Thrombosis* / diagnosis

Substances

Biomarkers
Oxygen